NGL: Test, Opiates, Over The Counter
What it covers
An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.
The identification in 21 CFR 862.3650, opiate test system. FDA gives NGL no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K253567 | Healgen Accurate Urine Drug Screen Dip Card; Healgen Accurate Home Urine Drug Test Dip Card | Healgen Scientific,, LLC | Dec 23, 2025 | Traditional |
| K250803 | Deepblue Multi-Drug Urine Test Cup; Deepblue Home Muti-Drug Urine Test Cup | Anhui Deepblue Medical Technological Co., Ltd. | Apr 15, 2025 | Traditional |
| K250067 | Dochek® Multi-Drug Urine Test Cup; Dochek® Multi-Drug Urine Test Cup Pro | Guangzhou Decheng Biotechnology Co., Ltd. | Feb 20, 2025 | Traditional |
| K242428 | Dochek® Fentanyl Urine Test Strip, Dochek® Fentanyl Urine Test Strip Plus, Dochek® Fentanyl Urine Test Card, Dochek® Fentanyl Urine Test Card Plus, Dochek® Fentanyl Urine Test Cup and Dochek® Fentanyl Urine Test Cup Plus | Guangzhou Decheng Biotechnology Co., Ltd. | Feb 6, 2025 | Traditional |
| K243365 | Healgen Accurate Muti-Drug Urine Drug Screen Cup; Healgen Accurate Home Muti-Drug Urine Test Cup | Healgen Scientific,, LLC | Dec 17, 2024 | Traditional |
| K243064 | ETERBIO Fentanyl/Norfentanyl Rapid Test (Colloidal Gold); ETERBIO Fentanyl/Norfentanyl Home Test | Eterbio, Inc. | Nov 20, 2024 | Traditional |
| K242802 | CLUNGENE Fentanyl Home Test Cassette; CLUNGENE Fentanyl Test Cassette | Hangzhou Clongene Biotech Co., Ltd. | Nov 8, 2024 | Traditional |
| K241869 | BioSieve Fentanyl FIA Home Test Kit; BioSieve Fentanyl FIA Pro Test Kit; BioSieve Toxismart Reader | Vivachek Biotech (Hangzhou) Co., Ltd. | Oct 4, 2024 | Traditional |
| K241969 | Hightop® Home Use Fentanyl/Norfentanyl Urine Rapid Test Panel; Hightop® Fentanyl/Norfentanyl Urine Rapid Test Panel | Qingdao Hightop Biotech Co., Ltd. | Aug 14, 2024 | Traditional |
| K241741 | SAFElife Fentanyl Urine Home Test (Cassette); SAFElife Fentanyl (FTY) Urine Test Cassette; SAFElife T-Dip Fentanyl Urine Home Test (Dip Card); SAFElife T-Dip Fentanyl (FTY) Urine Test Panel | Guangzhou Wondfo Biotech Co., Ltd. | Jul 16, 2024 | Traditional |
Clearances by year
21 NGL 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 4 | 39 |
| 2024 | 13 | 40 |
| 2023 | 1 | 16 |
| 2020 | 1 | 46 |
| 2019 | 1 | 28 |
| 2018 | 1 | 21 |
Who submits
15 applicants cleared a NGL device since 2011. 67% of the clearances went to applicants in China, then United States (33%). By type: Traditional 100%.
| Applicant | Clearances since 2011 |
|---|---|
| Healgen Scientific,, LLC | 4 |
| Hangzhou Clongene Biotech Co., Ltd. | 3 |
| Guangzhou Decheng Biotechnology Co., Ltd. | 2 |
| Allsource Screening Solutions | 1 |
| Anhui Deepblue Medical Technological Co., Ltd. | 1 |
| Assure Tech., LLC | 1 |
| Co-Innovation Biotech Co., Ltd. | 1 |
| Eterbio, Inc. | 1 |
How FDA classifies it
Class II (special controls). An opiate test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.
From 21 CFR 862.3650. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 862.3650 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NGL clearances declared.
Ask about NGL
Questions about NGL
What is FDA product code NGL?
Product code NGL, “Test, Opiates, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.3650 (opiate test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 23 clearances under NGL, 21 of them since 2011.
How many 510(k) clearances are there under NGL?
FDA’s 510(k) database listed 23 clearances under NGL as of Oct 29, 2026, 21 of them decided since 2011; the most recent decision was Dec 23, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a NGL 510(k)?
For the 7 NGL clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 49 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most NGL clearances?
Since 2011: Healgen Scientific,, LLC (4), Hangzhou Clongene Biotech Co., Ltd. (3), Guangzhou Decheng Biotechnology Co., Ltd. (2), Allsource Screening Solutions (1) and Anhui Deepblue Medical Technological Co., Ltd. (1). 15 applicants have cleared a NGL device in that time.